Related Experiment Videos
Blood transfusion: the silent epidemic
1Department of Anesthesiology, Virginia Commonwealth University/Medical College of Virginia, Richmond 23298-0695, USA. bdspiess@hsc.vcu.edu
The Annals of Thoracic Surgery
|November 28, 2001
Summary
The risk/benefit ratio of blood transfusions is unclear. While viral transmission risks are now minimal, physicians must consider immunosuppression, infection, and inflammatory events, as transfusion benefits remain understudied.
Area of Science:
- Transfusion Medicine
- Immunology
- Infectious Disease
Background:
- Historically, blood transfusion risks focused on viral transmission (hepatitis, HIV).
- Advanced screening has significantly reduced viral transmission risks.
- Current risks include immunosuppression, bacterial infection, ABO incompatibility, and transfusion-associated acute lung injury.
Purpose of the Study:
- To examine the risk/benefit ratio of allogeneic blood transfusions.
- To provide an evidence-based perspective in the post-AIDS era.
Main Methods:
- Literature review and analysis of transfusion risks and benefits.
- Focus on contemporary risks beyond viral transmission.
Main Results:
- Viral transmission risks are now negligible.
- Immunosuppression and inflammatory events are significant transfusion risks.
- The benefits of blood transfusion are not well-documented.
Conclusions:
- The risk/benefit ratio of blood transfusions is skewed.
- Physicians should carefully weigh risks against benefits, considering immunosuppression and inflammatory complications.
- Further research is needed to elucidate transfusion benefits.